By Tim Nerozzi
A California jury has $2 billion dollars to Alva and Alberta Pilliod determining that Roundup, a weed-killing product of the Monsanto corporation, was a “significant factor” in the couple’s ongoing health concerns.
Roundup Weed Preventer, a major brand of sprayable weed control formula, has been regularly linked to non-Hodgkin’s lymphoma in the past decade.
Alva was diagnosed with non-Hodgkin’s lymphoma in 2011. Just four years later, Alberta received the same prognosis.
“Glyphosate, the core ingredient in Monsanto’s Roundup weed products, is a human carcinogen causing Non-Hodgkin Lymphoma and other types of lymphoma including multiple myeloma and other diseases,” said the Environmental Litigation Group, a legal team specializing on similar cases of environmental and chemical negligence, on their website. “Studies show that prolonged exposure and use of glyphosate-based products, such as Roundup produced by Monsanto, may cause lymphoma cancer types.”
The Pilliod case (which was decided in Oakland, California) is the third successful lawsuit against Monsanto over the Roundup product.
Previous plantiffs, Edwin Hardeman and Dewayne Johnson, both developed the same cancerous disease, non-Hodgkin’s lymphoma, after extended use of the Roundup line of products.
Hardeman was awarded more than $80 million, and Johnson was awarded more than $78 million.
The sum of $2 billion to be awarded to the Pilliods is, by a wide margin, the most money that Monsanto has been forced to pay in these lawsuits.
Monsanto has expressed unhappiness with the decision and plans to appeal the case to a higher court. Bayer, Monsanto’s parent company, has repeatedly assured the public that Glyphosate is not a carcinogen and cannot cause non-Hodgkin’s lymphoma.
“Bayer is disappointed with the jury’s decision and will appeal the verdict in this case, which conflicts directly with the U.S. Environmental Protection Agency’s interim registration review decision released just last month,” Bayer said in an official statement released on after the conclusion of the trial.
Bayer instead blames the Pilliod’s poor medical histories and previous illnesses as the common factor in their identical diagnosis received just four years apart.
“We have great sympathy for Mr. and Mrs. Pilliod, but the evidence in this case was clear that both have long histories of illnesses known to be substantial risk factors for non-Hodgkin’s lymphoma (NHL), most NHL has no known cause, and there is not reliable scientific evidence to conclude that glyphosate-based herbicides were the ‘but for’ cause of their illnesses as the jury was required to find in this case.”
Bayer is a global, multi-national company who describes their products and services as “designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population.”
Thanks for being here and being a loyal reader. The American Media Institute covers stories other news outlets do not. We recruit reporters all over the world, investing money in translators, travel and document research. We are not a blog, which has few expenses beyond pajamas. Please help us continue to provide hard-hitting journalism by making a tax-deductible contribution today. Thank you.